The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bevova M.R.

GIGA Doctoral School for Health Sciences, University of Liège, Liège, Belgium

Netesov S.V.

Novosibirsk State University, Novosibirsk, Russia, 630090

Aul'chenko Iu.S.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny Sibirskogo otdeleniia RAN, Novosibirsk;
Institut tsitologii i genetiki Sibirskogo otdeleniia RAN, Novosibirsk

New coronavirus infection COVID-19

Authors:

Bevova M.R., Netesov S.V., Aul'chenko Iu.S.

More about the authors

Journal: Molecular Genetics, Microbiology and Virology. 2020;38(2): 51‑58

DOI: 10.17116/molgen20203802151

Views: 21059

Downloaded: 684

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Bevova MR, Netesov SV, Aul'chenko IuS. New coronavirus infection COVID-19. Molecular Genetics, Microbiology and Virology. 2020;38(2):51‑58. (In Russ.)
https://doi.org/10.17116/molgen20203802151

 
МСФ на ЯМ
Close metadata
Recommended articles:
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
Causes of hospital mortality in adults based on medi­cal certificates of death. Russian Journal of Preventive Medi­cine. 2024;(3):7-13
Anti­biotic resi­stance of the upper respiratory tract microbiota in children with the new coro­navirus infe­ction in Ryazan. Russian Journal of Preventive Medi­cine. 2024;(3):45-51
Comparison of the clinical performance of immu­nochromatographic tests for the dete­ction of SARS-CoV-2 anti­gens with data from inde­pendent studies. Labo­ratory Service. 2024;(1):13-19
Adve­rse peri­natal outcomes in COVID-19. Analysis of a series of clinical obse­rvations. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):86-90
Staging of COVID-19 morphological mani­festations in lungs depe­nding on disease dura­tion. Fore­nsic Medi­cal Expe­rtise. 2024;(2):28-31
Russian COVID-19 vaccines as a risk factor of myopericarditis in patients with or without previous infe­ction. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):184-193
Exosomes’ role in inte­rcellular inte­ractions in different variants of lung injury in fatal cases of COVID-19. Russian Journal of Archive of Pathology. 2024;(2):22-29
Age features of immu­nity to SARS-CoV-2 of metropolis popu­lation in the dyna­mics. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):118-128
Preadolescent acne. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):175-180

In December 2019, the first cases of pneumonia of unknown etiology emerged in Wuhan, China. Later, the pneumonia has been associated with the new coronavirus. In February 2020 the World Health Organisation (WHO) named a new disease COVID-19 and the virus causing it was named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (ICTV). By 11th of March, 2020, once the virus spread in more than 114 countries and resulted in 118,000 confirmed cases and a death toll of 4,000 the coronavirus outbreak has been declared a pandemic by the WHO. By the time of writing this article (April, 16, 2020) the virus has infected more than 2 millions and killed approximately 134 thousands people. In this review we summarize the current information about origin and spread of the SARS-CoV-2. We also review epidemiology, diagnostic, clinical features and treatment of COVID-19.

Keywords:

coronavirus
COVID-19
SARS-CoV-2
epidemiology

Authors:

Bevova M.R.

GIGA Doctoral School for Health Sciences, University of Liège, Liège, Belgium

Netesov S.V.

Novosibirsk State University, Novosibirsk, Russia, 630090

Aul'chenko Iu.S.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny Sibirskogo otdeleniia RAN, Novosibirsk;
Institut tsitologii i genetiki Sibirskogo otdeleniia RAN, Novosibirsk

List of references:

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.
  2. Coronavirus disease 2019 (COVID-19) Situation Report — 26. World Health Organisation. February 15, 2020. Accessed March 28, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200215-sitrep-26-covid-19.pdf?sfvrsn=a4cc6787_2
  3. Virtual press conference on COVID-19 — 11 March 2020. World Health Organisation. March 11, 2020. Accessed March 25, 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2
  4. Coronavirus disease 2019 (COVID-19) Situation Report — 51. World Health Organisation. March 11, 2020. Accessed March 28, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
  5. Coronavirus disease 2019 (COVID-19) Situation Report — 83. World Health Organisation. April 12, 2020. Accessed April 13, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4
  6. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316
  7. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014;14(1):407.
  8. Li P, Fu J-B, Li K-F, Chen Y, Wang H-L, Liu L-J, et al. Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster. Int J Infect Dis. 2020. https://doi.org/10.1016/j.ijid.2020.03.027
  9. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020. https://doi.org/10.1126/science.abb3221
  10. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970-971.
  11. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. March 2020. https://doi.org/10.1056/NEJMc2004973
  12. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.
  13. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020. https://doi.org/10.1016/j.cub.2020.03.022
  14. Andersen KG, Rambaut A, Ian Lipkin W, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nature Medicine. 2020. https://doi.org/10.1038/s41591-020-0820-9
  15. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6):490-502.
  16. ICTV Taxonomy. International Committee on Taxonomy of Viruses (ICTV). Accessed March 29, 2020. https://talk.ictvonline.org/taxonomy/
  17. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7(6):439-450.
  18. Drosten C, Günther S, Preiser W, van der Werf S, Brodt H-R, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967-1976.
  19. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-1820.
  20. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020. https://doi.org/10.1016/j.cell.2020.02.052
  21. Callaway E. Labs rush to study coronavirus in transgenic animals — some are in short supply. Nature. 2020;579(7798):183.
  22. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020. https://doi.org/10.1126/science.abb7015
  23. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032
  24. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. https://doi.org/10.1001/jama.2020.2648
  25. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. https://doi.org/10.1001/jama.2020.4683
  26. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 3 March 2020. World Health Organisation. March 3, 2020. Accessed March 25, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020.
  27. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020. https://doi.org/10.1016/s0140-6736(20)30566-3
  28. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30176-6
  29. Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr. 2020. https://doi.org/10.1001/jamapediatrics.2020.0878
  30. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60.
  31. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-815.
  32. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang Z-J. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020. https://doi.org/10.1001/jama.2020.2131
  33. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
  34. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.
  35. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020. https://doi.org/10.1002/jmv.25748
  36. Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020. https://doi.org/10.1038/s41418-020-0530-3
  37. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus—Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
  38. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2431.
  39. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273.
  40. Specific primers and probes for detection 2019 novel coronavirus. Chinese National Institute for Viral Disease Control and Prevention. January 21, 2020. Accessed March 25, 2020. http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html.
  41. Sheridan C. Fast, portable tests come online to curb coronavirus pandemic. Nat Biotechnol. 2020. https://doi.org/10.1038/d41587-020-00010-2
  42. Subbaraman N. Coronavirus tests: researchers chase new diagnostics to fight the pandemic. Nature. 2020. https://doi.org/10.1038/d41586-020-00827-6
  43. Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020. https://doi.org/10.1007/s00330-020-06731-x
  44. Li M, Lei P, Zeng B, Li Z, Yu P, Fan B, et al. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Acad Radiol. 2020. https://doi.org/10.1016/j.acra.2020.03.003
  45. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929-936.
  46. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med45. 2020. https://doi.org/10.1056/NEJMoa2001282
  47. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-271.
  48. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;105949.
  49. Kupferschmidt K. WHO launches global megatrial of the four most promising coronavirus treatments. Science. 2020. https://doi.org/10.1126/science.abb8497
  50. Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 2013;11(12):836-848.
  51. Qiu J. Covert coronavirus infections could be seeding new outbreaks. Nature. 2020. https://doi.org/10.1038/d41586-020-00822-x
  52. Enserink M. Mathematics of life and death: How disease models shape national shutdowns and other pandemic policies. Science. 2020. https://doi.org/10.1126/science.abb8814
  53. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 16 March 2020. World Health Organisation. March 16, 2020. Accessed March 25, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020
  54. What we learn about the Corona virus through waste water research — KWR. KWR. March 24, 2020. Accessed March 28, 2020. https://www.kwrwater.nl/en/actueel/what-can-we-learn-about-the-corona-virus-through-waste-water-research/
  55. Lawton G. Can you catch the coronavirus twice? We don’t know yet. New Scientist. March 2020. Accessed March 25, 2020. https://www.newscientist.com/article/mg24532754-600-can-you-catch-the-coronavirus-twice-we-dont-know-yet/
  56. Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv. 2020:2020.03.13.990226. https://doi.org/10.1101/2020.03.13.990226
  57. Zheng F, Liao C, Fan Q-H, Chen H-B, Zhao X-G, Xie Z-G, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020. https://doi.org/10.1007/s11596-020-2172-6
  58. King A. Possible Biological Explanations for Kids’ Escape from COVID-19. The Scientist Magazine. March 16, 2020. Accessed March 29, 2020. https://www.the-scientist.com/news-opinion/possible-biological-explanations-for-kids-escape-from-covid-19-67273
  59. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-116.
  60. Schouten LRA, Helmerhorst HJF, Wagenaar GTM, Haltenhof T, Lutter R, Roelofs JJTH, et al. Age-Dependent Changes in the Pulmonary Renin-Angiotensin System Are Associated With Severity of Lung Injury in a Model of Acute Lung Injury in Rats. Crit Care Med. 2016;44(12):1226-1235.
  61. Xie X, Chen J, Wang X, Zhang F, Liu Y. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. 2006;78(19):2166-2171.
  62. Schouten LR, van Kaam AH, Kohse F, Veltkamp F, Bos LD, de Beer FM, et al. Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study. Ann Intensive Care. 2019;9(1):55.
  63. Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21(1):234.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.